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Key points summary 28	
• The lipid droplet (LD)-associated perilipin (PLIN) proteins promote IMTG storage, but whether 29	
the abundance and association of the PLIN proteins with LDs is related to the diverse lipid 30	
storage in muscle between trained and sedentary individuals is unknown. 31	
• We show that lipid infusion augments IMTG content in type I fibres of both trained and 32	
sedentary individuals.  Most importantly, despite there being no change in PLIN protein content, 33	
lipid infusion did increase the number of LDs connected with PLIN proteins in trained 34	
individuals only.  35	
• We conclude that trained individuals are able to redistribute the pre-existing pool of PLIN 36	
proteins to an expanded LD pool during a lipid infusion, and through this adaptation may 37	
support storage of fatty acids in IMTG. 38	
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Abstract 55	
Because the lipid droplet (LD)-associated perilipin (PLIN) proteins promote intramuscular triglyceride 56	
(IMTG) storage, we investigated the hypothesis that differential protein content of PLINs and their 57	
distribution with LDs may be linked to the diverse lipid storage in muscle between trained and sedentary 58	
individuals.  Trained (n=11) and sedentary (n=10) subjects, matched for age, sex and BMI, received 59	
either a 6-h lipid or glycerol infusion in the setting of a concurrent hyperinsulinaemic-euglycaemic 60	
clamp.  Sequential muscle biopsies (0-h, 2-h, 6-h) were analysed using confocal immunofluorescence 61	
microscopy for fibre type-specific IMTG content and PLIN associations with LDs.  In both groups lipid 62	
infusion increased IMTG content in type I fibres (trained: +62%, sedentary: +79%; P<0.05), but did 63	
not affect PLIN protein content.  At baseline, PLIN2 (+65%), PLIN3 (+105%) and PLIN5 (+53%; all 64	
P<0.05) protein content was higher in trained compared to sedentary individuals.  In trained individuals, 65	
lipid infusion increased the number of LDs associated with PLIN2 (+27%), PLIN3 (+73%) and PLIN5 66	
(+40%; all P<0.05) in type I fibres.  In contrast, in sedentary individuals lipid infusion only increased 67	
the number of LDs not associated with PLIN proteins.  Acute FFA elevation, therefore, induces a 68	
redistribution of PLIN proteins to an expanded LD pool in trained individuals only, and this may be 69	
part of the mechanism which enables fatty acids to be stored in IMTG.      70	
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Introduction 111	
Large intramuscular triglyceride (IMTG) stores in skeletal muscle of sedentary individuals are strongly 112	
associated with insulin resistance and an elevated risk of developing type 2 diabetes (Kelley et al., 1999; 113	
Goodpaster et al., 2001). Even larger IMTG stores are observed in endurance-trained athletes but this 114	
occurs in the presence of high insulin sensitivity, a phenomenon termed the “athlete’s paradox” 115	
(Goodpaster et al., 2001; van Loon et al., 2004).  Research addressing this concept suggests that lipid 116	
metabolites, such as diacylglycerols (DAGs) and ceramides (van Loon & Goodpaster, 2006; Samuel & 117	
Shulman, 2012), rather than IMTG per se, are mechanistically linked to insulin resistance in sedentary 118	
individuals, due to their ability to directly impair insulin signalling (Itani et al., 2002; Adams et al., 119	
2004).  Therefore, the metabolic consequences of a lipid overload seems to depend on whether fatty 120	
acids taken up by muscle accumulate as DAGs and/or ceramides or are stored as IMTG, as occurs in 121	
trained athletes.  In support, when trained and sedentary individuals underwent an Intralipid® infusion 122	
to acutely raise plasma free fatty acid (FFA) concentrations during a hyperinsulinaemic euglycaemic 123	
clamp (Chow et al., 2014), training status modified how the fatty acids were stored in skeletal muscle 124	
(Chow et al., 2014).  Specifically, fatty acids reflecting the composition of the Intralipid® infusion 125	
appeared in IMTG in trained individuals, whereas they accumulated in IMTG and DAGs in sedentary 126	
individuals (Chow et al., 2014).  The mechanisms by which trained individuals preferentially 127	
accumulate IMTG rather than DAGs in the setting of FFA elevation warrants further investigation. 128	
 129	
In skeletal muscle, IMTG are stored within cytosolic lipid droplets (LD) which have over 300 proteins 130	
incorporated into their phospholipid monolayer (Zhang et al., 2011), the most abundant of which are 131	
the perilipin (PLIN) family of proteins.  Much of our knowledge of the PLIN proteins in human skeletal 132	
muscle is generated from studies in which muscle samples are obtained from overnight-fasted 133	
participants under resting conditions.  This approach has revealed that the PLIN protein content is higher 134	
in type I compared to type II muscle fibres (Shaw et al., 2009; Shepherd et al., 2013; Pourteymour et 135	
al., 2015), and that PLIN2 and PLIN5 are observed at both the LD and non-LD locations (Shepherd et 136	
al., 2012, 2013).  Furthermore, exercise training augments protein levels of PLIN2, PLIN3 and PLIN5 137	
in skeletal muscle alongside a greater IMTG content (Shaw et al., 2012; Shepherd et al., 2013; Shepherd 138	
et al., 2014).  This suggests that during exercise training interventions the increase in PLIN protein 139	
content is proportional to the increase in IMTG levels.  It may also imply that the increase in PLIN 140	
protein content plays a mechanistic role in the increased IMTG content in trained individuals.  In support, 141	
IMTG accumulates in muscle cells overexpressing PLIN3 (Kleinert et al., 2016), and PLIN5 142	
overexpression in primary human myotubes promotes IMTG storage by restricting basal lipolytic rates 143	
(Laurens et al., 2016).  Moreover, myotubes overexpressing PLIN5 exhibit reduced DAG and ceramide 144	
accumulation in response to a palmitate overload (Laurens et al., 2016), and similarly when rats are fed 145	
a high-fat diet, muscle-specific overexpression of PLIN2 (Bosma et al., 2012a) or PLIN5 (Bosma et al., 146	
2012a; Bosma et al., 2013) promotes IMTG storage with no accumulation of DAG.  Collectively, these 147	
data suggest that the PLIN proteins may play an important role in enabling excess fatty acids to be 148	
stored in IMTG. 149	
 150	
Studying the PLIN proteins under ‘dynamic’ conditions, where IMTG levels are altered independently 151	
of changes in PLIN protein content, may provide further insight into their potential roles.  In accordance, 152	
we have shown that LDs containing either PLIN2 (Shepherd et al., 2012) or PLIN5 (Shepherd et al., 153	
2012, 2013) are preferentially used during moderate-intensity exercise, thereby highlighting a potential 154	
role for the PLIN proteins in the breakdown and oxidation of IMTG.  Gemmink et al. (Gemmink et al., 155	
2016) recently reported that prolonged fasting in trained individuals augmented IMTG content and 156	
increased the quantity of PLIN5 in contact with LDs, suggesting that the pre-existing PLIN5 pool is 157	
redistributed across the LD pool when it expands.  Furthermore, only an increase in the number and 158	
size of LDs that contained PLIN5 occurred (Gemmink et al., 2016), suggesting a role for PLIN5 in 159	
mediating IMTG storage.  This could be one mechanism for IMTG storage in muscle, which could be 160	
modified by endurance training.  It is yet to be investigated if a similar redistribution of other PLIN 161	
proteins occurs under conditions of elevated FFA exposure during a hyperinsulinaemic euglycaemic 162	
clamp.       163	
 164	
In order to further elucidate the roles of the PLIN proteins in skeletal muscle, the present study aimed 165	
to determine the effect of endurance training, compared to a sedentary condition, on the dynamic 166	
behaviour of LDs and PLIN proteins during acute, moderate FFA elevation concurrent to a 167	
hyperinsulinaemic-euglycaemic clamp.  Specifically, we used our previously described method 168	
(Shepherd et al., 2012, 2013) to identify changes in LDs that either contained (PLIN+ LDs) or were 169	
devoid of PLIN (PLIN- LDs) during the lipid infusion.  Lipid accumulation in muscle is not uniform 170	
across fibre types and therefore all analyses were performed on a fibre-type specific basis.  Importantly, 171	
the lipid infusion was undertaken in the setting of hyperinsulinaemia to maximise skeletal muscle fatty 172	
acid uptake (Dyck et al., 2001; Chabowski et al., 2004), suppress lipase activity (Holm et al., 2000) and 173	
drive TAG synthesis (Muoio et al., 1999; Dyck et al., 2001).  Therefore, we investigated the hypothesis 174	
that in response to simultaneous infusion of Intralipid® and insulin, the increase in IMTG storage in 175	
trained individuals would be accompanied by a redistribution of the cellular pool of PLIN proteins 176	
across the expanded LD pool. 177	
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Materials and Methods 195	
Participants and ethical approval 196	
The samples used in this study were collected as part of a previous study (Chow et al., 2012; Chow et 197	
al., 2014) and therefore a portion of the demographic data in Table 1 has been previously presented 198	
(Chow et al., 2012; Chow et al., 2014).  In this study, twenty one young, healthy, lean participants who 199	
were either trained (n=11) or sedentary (n=10) (see Table 1 for characteristics) were included and 200	
matched for sex, age (±5 yr) and BMI (±1.5 kg.m2).   The International Physical Activity Questionnaire 201	
was used to classify individuals as sedentary (30 minutes or less of exercise per week) or trained (history 202	
of aerobic training, preferably running, at ≥45 min/day, ≥5 days/wk) (Craig et al., 2003).  The study 203	
protocol adhered to the Declaration of Helsinki and was approved by the University of Minnesota 204	
Institutional Review Board and written, informed consent was obtained from all participants.  205	
 206	
Experimental protocol 207	
The protocol for the study has been described in detail previously (Chow et al., 2012; Chow et al., 208	
2014).  Briefly, after undergoing assessments of aerobic exercise capacity (VO2max), body composition 209	
(dual energy X-ray absorptiometry) and insulin sensitivity (3 h hyperinsulinaemic euglycaemic clamp), 210	
participants attended the Masonic Clinical Research Unit at the University of Minnesota on a separate 211	
day and consumed a standardised evening meal (41% carbohydrate, 32% fat, 27% protein) and 212	
remained on bed rest at the unit until study completion the following day.  Following an overnight fast, 213	
a muscle biopsy (Bx1) was obtained from the vastus lateralis under local anaesthesia, after which 214	
participants underwent 6 h infusion of either lipid (20% Intralipid® at 90 ml.h-1) or glycerol (2.25 g.100 215	
ml-1 at 90 ml.h-1).  The glycerol infusion matched the glycerol content of the lipid infusion.  Participants 216	
received either a lipid or glycerol infusion to maintain matching between activity groups.  Simultaneous 217	
to the lipid or glycerol infusion, a 6 h hyperinsulinaemic euglycaemic clamp was initiated (1.5 mIU.kg 218	
free fat mass-1.min-1, KPO4 at 50 ml.h-1, dextrose titrated to maintain glucose at 4.7-5.3 mmol.l-1).  After 219	
starting the lipid or glycerol infusion, a second muscle biopsy (Bx2; 120 min) was obtained from a 220	
proximal incision of the same leg, with a third biopsy (Bx3; 360 min) being obtained from the 221	
contralateral leg.  Each muscle biopsy was dissected free of fat and connective tissue before being 222	
embedded in Tissue-Tek OCT Compound (Sakura Finetek Europe) and frozen in liquid nitrogen-cooled 223	
isopentane for immunohistochemical analyses.  224	
 225	
Muscle analysis 226	
Immunohistochemistry 227	
Serial 5 µm cryosections were cut at -30°C and transferred on to ethanol-cleaned glass slides, fixed in 228	
3.7% formaldehyde and permeabilized for 5 min in 0.5% Triton-X 100, followed by washing in 229	
phosphate-buffered saline (PBS) and then incubated for 1 h with primary antibodies targeting either 230	
PLIN2, PLIN3, PLIN4 or PLIN5 (see antibody section for details) in combination with a myosin 231	
antibody for slow-twitch fibres.  After washing with PBS, sections were subsequently incubated with 232	
appropriate Alexa Fluor secondary antibodies for 30 min, washed in PBS again, and then incubated 233	
with BODIPY 493/503 (Invitrogen, Paisley, UK) in order to image and quantify IMTG.  Cover slips 234	
were mounted with Vectashield mounting medium (H-1000, Vector Laboratories, Burlingame, CA, 235	
USA) and sealed with nail varnish.  Fibre type-specific protein expression of PLIN2, PLIN3, PLIN4 236	
and PLIN5 was assessed using the same protocol but with the omission of BODIPY 493/503 from the 237	
procedure, as previously described (Shepherd et al., 2012, 2013). 238	
 239	
Antibodies 240	
The following primary antibodies were used: guinea pig polyclonal anti-OXPAT (PLIN5) and guinea 241	
pig polyclonal anti-S3-12 (PLIN4: both Progen Biotechnik, Germany), mouse monoclonal anti-242	
adipophilin (PLIN2: American Research Products, MA, USA), rabbit polyclonal anti perilipin 3/TIP-243	
47 (PLIN3: Novus Biologicals, Cambridge, UK), mouse anti-myosin antibody for slow twitch fibres 244	
(A4.840-c, DSHB, developed by Dr. Blau), wheat germ agglutinin Alexa Fluor 350 conjugate 245	
(Invitrogen, Paisley, UK).  Appropriate Alexa Fluor secondary antibodies were obtained from 246	
Invitrogen (Paisley, UK). 247	
 248	
Image capture, processing and data analysis 249	
Images of cross-sectionally orientated sections were used for determining fibre type-specific differences 250	
in the protein expression of IMTG, PLIN2, PLIN3, PLIN4, and PLIN5.  Images were captured using 251	
an inverted confocal microscope (Zeiss LSM710, Carl Zeiss AG, Oberkochen, Germany) with a 40x 252	
0.75 NA oil immersion objective.  An argon laser was used to excite the Alexa Fluor 488 fluorophore 253	
and BODIPY, whilst a helium-neon laser excited the Alexa Fluor 546 and 633 fluorophores.  Images to 254	
assess LD characteristics and co-localisation with either PLIN2, PLIN3, PLIN4 or PLIN5 were captured 255	
with the same system but using an 8x digital zoom.  When assessing fibre-specific content of IMTG 256	
and individual PLIN proteins, fibres stained positively for myosin heavy chain type I were classified as 257	
type I fibres, whereas those with no staining were classified as type II fibres. 258	
 259	
Image processing was undertaken using Image-Pro Plus 5.1 Software (Media Cybernetics, MD, USA).  260	
To assess fibre type distribution of IMTG and each PLIN protein, between 8 and 12 images were used 261	
per muscle section, resulting in a similar proportion of fibres being analysed for each trained (97±10 262	
type I fibres, 118±15 type II fibres) and sedentary participant (105±17 type I fibres, 125±17 type II 263	
fibres).  An intensity threshold was uniformly selected to represent a positive signal for IMTG and each 264	
PLIN protein.  The content of IMTG and each PLIN protein was expressed as the positively stained 265	
area fraction relative to the total area of each muscle fibre.  Images captured at 8x digital zoom were 266	
used to identify changes in LD density (number of LDs expressed relative to area) and LD size (mean 267	
area of individual LDs). 268	
 269	
Co-localisation analysis was performed separately for each PLIN protein with IMTG, as described 270	
previously for PLIN2 and PLIN5 (Shepherd et al., 2013).  Briefly, a positive signal for the PLIN protein 271	
of interest and IMTG in sequential images was obtained by selecting a uniform intensity threshold (Fig. 272	
1A-C). Based on the selected threshold, binary images were created and subsequently used for co-273	
localisation analysis.  A co-localisation map displaying the merged images was generated (Fig. 1D), 274	
with the overlapping regions subsequently extracted to a separate image (Fig. 1E).  First, the total 275	
number of extracted objects in this image as a proportion of the total number of PLIN2 objects (or 276	
PLIN3, PLIN4 or PLIN5 objects, depending on the analysis performed) was used as a measure of co-277	
localisation.  The number of extracted objects was expressed relative to area and therefore represents 278	
the density of PLIN-associated LDs (PLIN+ LDs).  In addition, the number of extracted objects was 279	
subtracted from the total number of LDs, and expressed relative to area, to quantify the density of LDs 280	
not associated with PLIN (PLIN- LDs).  Finally, the number of extracted objects was subtracted from 281	
the total number of PLIN objects (an expressed relative to area) to determine the density of “free PLIN”.  282	
The PLIN proteins do not always form a continuous structure around the LD, and are therefore observed 283	
as several discrete structures on the LD.  Consequently, it is possible that two or more extracted objects 284	
are derived from the same LD leading to an overestimation of the PLIN+ LDs.  This possibility was 285	
accounted for during the colocalisation analysis.  As previously described (Shepherd et al., 2012, 2013), 286	
several controls were performed to check for bleed through, non-specific secondary antibody binding 287	
and autofluorescence before co-localisation analysis was performed. 288	
 289	
Statistical analysis 290	
All baseline data are reported as means ± S.E.M.  A two-tailed t-test was used to determine significant 291	
differences at baseline between groups.  Multiple group comparisons of LD, PLIN protein expression 292	
and LD-PLIN co-localisation variables were performed as follows: 1) trained lipid vs. trained glycerol, 293	
2) sedentary lipid vs. sedentary glycerol, 3) trained lipid vs. sedentary lipid, and 4) trained glycerol vs. 294	
sedentary glycerol.  Linear mixed effects models, with random intercepts to account for repeated 295	
measurements within subjects, were used to examine these group differences, as well as differences 296	
over the infusion (across biopsies) and between fibre types.  LD, PLIN protein expression and LD-PLIN 297	
co-localisation variables are reported as least square means ± S.E.M.  Pairwise differences between 298	
biopsies were performed using post hoc tests.  Significance was set at the 0.05 level of confidence.  All 299	
analyses were conducted with SAS (version 9.2; SAS Institute, Cary, NC).    300	
 301	
 302	
 303	
 304	
Results 305	
Baseline characteristics 306	
As expected due to matching, there was no differences between sedentary and trained participants for 307	
age and BMI (Table 1).  Trained participants displayed lower body fat, and higher free-fat mass, VO2max 308	
and glucose infusion rate (GIR) compared to sedentary participants (Table 1).   309	
 310	
At baseline, all PLIN proteins displayed a fibre type-specific distribution, such that PLIN protein 311	
content (expressed as % area stained; Fig. 2) was significantly greater in type I fibres compared with 312	
type II fibres, irrespective of training status (P<0.05).  Compared to sedentary participants, trained 313	
participants had higher PLIN2, PLIN3, and PLIN5 protein content (P<0.05) in both type I and type II 314	
fibres (Fig. 2).  A trend for greater PLIN4 protein content in type I fibres of trained participants (P=0.06; 315	
Fig. 2C) compared to sedentary participants was also observed, whereas no differences between groups 316	
was evident for PLIN4 content in type II fibres.  IMTG content was significantly greater in type I fibres 317	
compared with type II fibres in both trained and sedentary participants (P<0.001), but overall IMTG 318	
content was similar between groups (Fig. 3A). 319	
 320	
Lipid droplet responses to lipid infusion 321	
During the hyperinsulinaemic euglycaemic clamp, lipid infusion elevated FFA concentrations, although 322	
this occurred to a greater degree in sedentary (932±105 µmol.L-1) compared to trained participants 323	
(600±86 µmol.L-1; P=0.03, Table 1).  The glycerol infusion combined with the hyperinsulinaemic 324	
euglycaemic clamp led to comparable suppression of FFA concentrations between groups (P=0.91).  325	
Lipid infusion significantly increased IMTG content in type I fibres of both trained (+62%; P=0.001 326	
for Bx3 vs. Bx1) and sedentary participants (+79%; P=0.02 for Bx3 vs. Bx1), with no differences 327	
between groups (Fig. 3A).  In trained participants, the greater IMTG content following lipid infusion 328	
was attributed to an increase in both LD density (+97%; P=0.01 for Bx3 vs. Bx1) and LD size (+22%; 329	
P=0.03 for Bx3 vs. Bx1), whereas in type I fibres of sedentary participant’s lipid infusion only led to 330	
an increase in LD density (+64%; P=0.03 for Bx3 vs. Bx1; Fig. 3B & C).  Interestingly, lipid infusion 331	
also increased LD size in type II fibres of trained participants (+64%; P=0.03 for Bx3 vs. Bx1; Fig. 3C), 332	
but this did not result in a significant overall increase in IMTG content in type II fibres.  Furthermore, 333	
IMTG content was not elevated in type II fibres of sedentary participants following lipid infusion.  334	
 335	
Lipid droplet and PLIN protein co-localisation 336	
Lipid infusion had no effect on the protein content of any of the PLINs in either trained or sedentary 337	
participants (P>0.05; Fig. 2).  We next investigated the association between LD and each PLIN protein 338	
by expressing the number of overlapping objects relative to the total number of PLIN protein objects 339	
(Fig. 1).  Further, we also determined the number of LDs that either contained (PLIN+ LD) or were 340	
devoid of each PLIN protein (PLIN- LD) in response to the combined lipid and insulin infusion.  The 341	
results of these analyses are detailed below. 342	
 343	
PLIN2:  At baseline, the fraction of PLIN2 co-localised with IMTG was similar between the groups in 344	
type I fibres (Trained: 0.65±0.02, Sedentary 0.68±0.02), and lipid infusion did not change this 345	
relationship.  However, lipid infusion did lead to an increase in the number of PLIN2+ LDs in trained 346	
participants (+27%; P=0.01 for Bx3 vs. Bx1; Fig. 4A) but no changes occurred in the sedentary group.  347	
In contrast, the number of PLIN2- LDs was elevated by lipid infusion by a similar degree in both groups 348	
(Trained: +69%, Sedentary: +69%; P<0.05 for Bx3 vs. Bx1 for both groups; Fig. 4B).  In type II fibres, 349	
the fraction of PLIN2 co-localised with IMTG was similar between the groups at baseline (Trained: 350	
0.59±0.03, Sedentary 0.65±0.04).  Lipid infusion increased PLIN2 co-localisation with IMTG from 351	
baseline (0.59±0.03) to post-infusion (0.71±0.03) in type II fibres in trained participants only (+21%; 352	
P=0.001 for Bx3 vs. Bx1).  This was accounted for by a 33% significant decrease in free PLIN2 in 353	
response to lipid infusion (0.006±0.002 vs. 0.005±0.001 PLIN2 objects.µm2 for Bx1 and Bx3, 354	
respectively; P=0.004). 355	
 356	
PLIN3: There was no difference between trained and sedentary groups when comparing the fraction of 357	
PLIN3 co-localised with IMTG in both type I (Trained: 0.67±0.04, Sedentary 0.64±0.04) and type II 358	
fibres (Trained: 0.62±0.05, Sedentary: 0.61±0.05; P>0.05), and this relationship was unchanged by lipid 359	
infusion.  However, lipid infusion did lead to an increase in the number of PLIN3+ LDs in type I fibres 360	
of trained participants (+73%; P=0.004 for Bx3 vs. Bx1; Fig. 5A), whereas no changes occurred in the 361	
sedentary group.  In contrast, in sedentary participants lipid infusion augmented the number of PLIN3- 362	
LDs (+133%; P<0.001 for Bx3 vs. Bx1; Fig. 5B) in type I fibres, with no changes in the trained group.  363	
Furthermore, no changes in the number of PLIN3+ or PLIN3- LDs occurred in type II fibres in either 364	
group in response to lipid infusion.  365	
 366	
PLIN4: A similar fraction of PLIN4 co-localised with IMTG when comparing trained and sedentary 367	
groups at baseline in both type I (Trained: 0.74±0.05, Sedentary 0.70±0.06) and type II fibres (Trained: 368	
0.66±0.06, Sedentary 0.66±0.07; P>0.05).  Lipid infusion had no effect on this relationship, and no 369	
increase in PLIN4+ LDs was observed in either group (Fig. 6A & C).  However, the number of PLIN4- 370	
LDs was elevated in type I fibres following lipid infusion in both trained (+55%; P=0.005 for Bx3 vs. 371	
Bx1) and sedentary participants (+94%; P=0.02 for Bx3 vs. Bx1; Fig. 6B). 372	
 373	
PLIN5: The fraction of PLIN5 co-localised with IMTG was similar between trained and sedentary 374	
groups at baseline in both type I (Trained: 0.64±0.04, Sedentary 0.58±0.04; P>0.05) and type II fibres 375	
(Trained: 0.63±0.03, Sedentary 0.61±0.04; P>0.05).  Lipid infusion led to an increase in PLIN5 co-376	
localised with IMTG from baseline (0.58±0.04) to post-infusion (0.71±0.03) in type I fibres of sedentary 377	
participants only (+21%; P=0.013 for Bx3 vs. Bx1).  This occurred alongside a trend for a decrease in 378	
free PLIN5 in response to lipid infusion (0.011±0.002 vs. 0.008±0.002 for Bx1 and Bx3, respectively; 379	
P=0.089).  Notably, however, the number of PLIN5+ LDs was only augmented by lipid infusion in type 380	
I fibres of trained participants (+40; P=0.006 for Bx3 vs. Bx1; Fig. 7A), whereas the number of PLIN5- 381	
LDs was elevated by lipid infusion only in type I fibres of sedentary participants (+123%; P=0.03 for 382	
Bx3 vs. Bx1; Fig. 7B).  383	
 384	
 385	
 386	
Discussion  387	
This study examined the effect of training on the muscle LD pool and the association of the PLIN 388	
proteins with LDs in response to acute FFA elevation (through infusion of Intralipid®) alongside a 389	
hyperinsulinaemic-euglycaemic clamp.  The major novel observations are that acutely elevating FFA 390	
concentrations alongside hyperinsulinaemia: 1) augments IMTG content in type I fibres of both trained 391	
and sedentary individuals, but that increases in the number and/or size of LDs are dependent on training 392	
status, 2) increased the number of LDs associated with PLIN2, PLIN3 and PLIN5 in trained individuals, 393	
and 3) led to the accumulation of LDs that were not associated with any of the PLIN proteins in 394	
sedentary individuals.  Together, and in line with our hypothesis, these data indicate that the ability to 395	
redistribute PLIN proteins to the expanded LD pool under conditions stimulating IMTG synthesis is 396	
unique to trained individuals.    397	
 398	
The first novel finding of the present study was that acute FFA elevation and insulin infusion led to an 399	
increase in IMTG content that was specific to type I fibres in both trained and sedentary individuals.  400	
Previously, IMTG content was not significantly elevated by acute FFA elevation when analysed in 401	
whole muscle homogenates (Chow et al., 2014), highlighting the importance of considering fibre type-402	
specific responses when investigating adaptations to the intramuscular lipid pool.  Hyperinsulinaemia 403	
will increase fatty acid uptake into muscle (Dyck et al., 2001; Chabowski et al., 2004), suppress 404	
intramuscular lipase activity (Holm et al., 2000), and enhance fatty acid triacylglycerol esterification 405	
(Muoio et al., 1999; Dyck et al., 2001), and when combined with acute FFA elevation it is likely that 406	
these conditions underpin the net increase in IMTG content.  It is notable that the increase in IMTG 407	
content in trained individuals was attributable to both a greater LD number and size, whereas only an 408	
increase in LD number could explain the higher IMTG content following acute FFA elevation in 409	
sedentary participants.  An increase in LD number could be deemed advantageous since this would 410	
maintain a high LD surface area to volume ratio, thereby providing a greater surface area available for 411	
LD regulatory proteins (such as PLINs) to support fatty acid storage and mobilisation relative to 412	
metabolic demand.  A combined increase in LD number and size in trained individuals was reported in 413	
a recent study using prolonged fasting to physiologically raise plasma FFA concentrations (Gemmink 414	
et al., 2016).  As well as synthesising new LDs, expanding the size of LDs, may be an additional 415	
mechanism by which trained individuals are able to sequester excess plasma FFA into IMTG.   416	
 417	
Under resting conditions, the expression of PLIN2 and PLIN5 is closely related to IMTG content 418	
(Minnaard et al., 2009; Amati et al., 2011; Peters et al., 2012; Shepherd et al., 2013), although not all 419	
PLIN2 or PLIN5 is associated with the IMTG pool (Shepherd et al., 2012, 2013).  The results of the 420	
present study now show that this partial co-localisation with IMTG also exists for PLIN3 and PLIN4.  421	
In response to acute FFA elevation, IMTG levels were increased independent of changes in PLIN 422	
protein content.  We therefore investigated whether acute FFA elevation altered the fraction of each 423	
PLIN associated with IMTG, and for each PLIN protein we describe two pools of LDs: (1) PLIN-424	
associated LDs (PLIN+ LD), and (2) LDs that do not contain PLIN (PLIN- LDs).  The major novel 425	
finding of the present study was that in trained individuals, acute FFA elevation led to an increase in 426	
the number of PLIN2+, PLIN3+ and PLIN5+ LDs specifically in type I fibres.  Furthermore, this 427	
occurred in the absence of a change in the fraction of any PLIN protein associated with IMTG.  428	
Gemmink et al. (2016) recently showed that in trained individuals elevating plasma FFA concentrations 429	
through prolonged fasting also led to a greater number of PLIN5+ LDs, but this was accompanied by 430	
an increase in the fraction of PLIN5 associated with IMTG.  Since PLIN5 protein expression was 431	
unaltered by fasting in this study, the authors concluded that prolonged fasting led to a redistribution of 432	
cytosolic PLIN5 to the LD surface (Gemmink et al., 2016).  We now provide evidence that in trained 433	
individuals PLIN2, PLIN3 and PLIN5 are all redistributed across the expanded LD pool following acute 434	
FFA elevation.  However, as we did not observe a change in the fraction of any PLIN protein associated 435	
with IMTG, it appears that PLIN2, PLIN3 and PLIN5 are redistributed from pre-existing PLIN+ LDs 436	
to either newly-synthesised LDs and/or pre-existing PLIN- LDs.  As a result, the proportion of the 437	
expanded LD pool containing these PLIN proteins was maintained.   438	
 439	
The redistribution of PLIN2, PLIN3 and PLIN5 in trained individuals may be an important adaptation 440	
to enable FFA storage as IMTG in LDs.  In support, palmitate incorporation into IMTG is reduced when 441	
PLIN2 is knocked-down in cultured muscle cells (Bosma et al., 2012a), whereas PLIN3 overexpression 442	
in muscle cells increases palmitate incorporation into IMTG (Kleinert et al., 2016).  Furthermore, 443	
muscle-specific overexpression of PLIN2 (Bosma et al., 2012a) or PLIN5 (Bosma et al., 2013) 444	
enhances IMTG storage in rats fed a high-fat diet.  PLIN5 overexpression in primary human myotubes 445	
also leads to an increase in IMTG content by restricting rates of basal lipolysis (Laurens et al., 2016).  446	
In this regard, there is a large body of evidence obtained in a number of different cell types 447	
demonstrating that the PLIN proteins support triacylglycerol storage by regulating basal lipolytic rates 448	
(reviewed in MacPherson & Peters, 2015).  Through this role, PLIN5 (and PLIN2 and PLIN3) may lead 449	
to enlargement of LDs, and could therefore explain the observed increase in LD size in trained 450	
individuals.  PLIN2 also has been observed to cluster at specific locations in the endoplasmic reticulum 451	
membrane where LD biogenesis occurs (Robenek et al., 2006).  In trained individuals, part of the PLIN2 452	
protein pool may therefore be redistributed to the membrane of the endoplasmic reticulum in response 453	
to acute FFA elevation to support the synthesis of new LDs.  Maintaining the proportion of the LD pool 454	
that contains PLIN2, PLIN3 and PLIN5 may also be important to support mobilisation and oxidation 455	
of IMTG-derived FAs when metabolic demand increases.  We have shown that both PLIN2+ and 456	
PLIN5+ LDs (Shepherd et al., 2013) are preferentially targeted for breakdown during exercise.  This is 457	
in line with studies in cultured cells demonstrating that PLIN5 overexpression enhances triacylglycerol 458	
hydrolysis and fat oxidation, possibly by recruiting LDs to the mitochondrial network (Wang et al., 459	
2011; Bosma et al., 2012b; Laurens et al., 2016).  A positive association is also reported between PLIN3 460	
expression and both whole-body fat oxidation (Covington et al., 2014) and ex vivo palmitate oxidation 461	
(Covington et al., 2014; Covington et al., 2015), and PLIN3 is observed in the mitochondrial fraction 462	
of sedentary and endurance-trained rats (Ramos et al., 2015), suggesting that PLIN3 plays a role in 463	
IMTG oxidation.  Taken together, these data suggest that redistributing PLIN2, PLIN3 and PLIN5 in 464	
response to acute FFA elevation would confer a metabolic advantage by maintaining a metabolically 465	
flexible intramuscular LD pool. 466	
 467	
In contrast to the trained group, acute FFA elevation led to an increase in the number of PLIN2-, PLIN3-, 468	
PLIN4-, and PLIN5- LDs in sedentary individuals, suggesting that no redistribution of these proteins 469	
occurred.  The protein content of all PLINs was lower in sedentary individuals compared to the trained 470	
group, and therefore it is possible that sedentary individuals have a reduced capacity to redistribute 471	
PLINs when the muscle LD pool expands.  Knockdown of PLIN2 in cultured muscle cells leads to 472	
increased palmitate incorporation into DAG (Bosma et al., 2012a), whereas rats fed a high-fat diet 473	
accumulated IMTG, with no changes in DAG, but only when PLIN2 (Bosma et al., 2012a) or PLIN5 474	
(Bosma et al., 2013) was overexpressed in muscle.  PLIN2 and PLIN5 therefore appear to be important 475	
in channelling fatty acids into IMTG.  The lack of a redistribution and/or lower abundance of these 476	
proteins in the present study may explain our previous finding that fatty acids reflecting the composition 477	
of an Intralipid® infusion appeared in IMTG and DAGs in sedentary individuals and only IMTG in 478	
trained individuals (Chow et al., 2014). 479	
 480	
Although IMTG content was unchanged in type II fibres, LD size did increase in trained individuals 481	
following acute FFA elevation.  In addition, the fraction of PLIN2 associated with IMTG was increased, 482	
and therefore PLIN2 might also be redistributed to LDs in type II fibres, possibly to ensure that the 483	
surface coverage of larger LDs is maintained.  Although PLIN2 is considered to be predominantly found 484	
at the LD surface (Prats et al., 2006; Wolins et al., 2006; Bell et al., 2008), PLIN2 has also been 485	
observed at the endoplasmic reticulum (Robenek et al., 2006), and may cycle between the cytosolic and 486	
LD fractions (Robenek et al., 2006; Wang et al., 2009).  Since there was a significant decrease in PLIN2 487	
that was unbound to LDs (free PLIN2) following acute FFA elevation, it is possible therefore that in 488	
type II fibres PLIN2 that was not previously associated with LDs became connected to the LD pool.  489	
Similarly, in sedentary individuals acute FFA elevation led to an increase in the fraction of PLIN5 490	
associated with LDs in type I fibres.  Like the aforementioned changes in PLIN2 in type II fibres of 491	
trained individuals, it is possible that PLIN5 that was previously not associated with LDs was recruited 492	
to the LD pool in type I fibres of sedentary individuals, especially as there was a tendency for PLIN5 493	
that was unbound to LDs to decrease.  However, because in sedentary individuals only an increase in 494	
the number of PLIN5- LDs was observed, it is likely that previously unbound PLIN5 was recruited to 495	
LDs already coated with PLIN5.    496	
 497	
Little is known about the role of PLIN4 in skeletal muscle, although we report for the first time here 498	
that PLIN4 expression is ~2-fold greater in type I compared to type II fibres, and that trained individuals 499	
exhibit higher protein expression of both PLIN4 compared to sedentary individuals.  These observations 500	
are in accordance with the fibre type distribution of the other PLINs in skeletal muscle, and findings of 501	
greater PLIN2, PLIN3 and PLIN5 expression in muscle in response to chronic training (Peters et al., 502	
2012; Shaw et al., 2012; Louche et al., 2013; Shepherd et al., 2013; Shepherd et al., 2014).  Despite the 503	
higher PLIN4 expression in trained individuals, we only observed an increase in PLIN4- LDs 504	
suggesting that no redistribution of PLIN4 occurred in response to acute FFA elevation.  Future studies 505	
will determine the precise role of PLIN4 in human skeletal muscle.   506	
 507	
The use of validated immunofluorescence microscopy techniques (Shepherd et al., 2012, 2013) to 508	
examine fibre type-specific changes in LD characteristics and the associations of PLIN proteins with 509	
LDs in response to acute FFA elevation is a clear strength of this study.  Applying these techniques to 510	
samples obtained under ‘dynamic’ conditions has provided further insight into the potential role of the 511	
PLIN proteins in muscle.  Our colocalisation assays, however, only permit fibre-specific analysis of the 512	
association between LDs and a single PLIN protein.  This is important to acknowledge because acute 513	
FFA elevation increased PLIN4- LDs in trained and sedentary individuals, and increased both PLIN2+ 514	
and PLIN2- LDs in trained individuals.  One possibility is that PLIN- LDs are actually newly-formed 515	
LDs that have not yet acquired sufficient PLIN protein to exceed the lower detection limit of the 516	
microscope.  It is also possible that PLIN4- LDs and PLIN2- LDs were in fact coated with PLIN3 and/or 517	
PLIN5.  Co-localisation analysis of PLIN2 and PLIN5 in rat skeletal muscle demonstrated only a partial 518	
overlap between the two proteins (Macpherson et al., 2012), suggesting that some, but not all LDs, have 519	
both of these proteins associated with them.  Whether there are distinct pools of LDs in skeletal muscle 520	
that have all, some, or none of the PLIN proteins associated remains to be determined. 521	
 522	
Although exercise capacity was significantly different between the trained and sedentary participants, 523	
the mean VO2max for the trained group was lower than that reported for previously published ‘trained’ 524	
groups (van Loon et al., 2004; Amati et al., 2011), which may explain the lack of difference in baseline 525	
IMTG between trained and sedentary participants that we observed compared with previous literature 526	
(Goodpaster et al., 2001; Amati et al., 2011). We consider this a strength of the study because it 527	
demonstrates that only a small increase in exercise capacity, as can be achieved using exercise training, 528	
can improve the ability to redistribute PLIN proteins to LDs during acute FFA elevation and channel 529	
fatty acids into IMTG.  In addition, since we had matched for age, gender and BMI, the trained 530	
participants consistently had a higher VO2 max than their matched counterparts and therefore our findings 531	
were still consistent with a training effect.  A further strength of the study is the use of a glycerol infusion 532	
as a control, as this approach enabled the specific examination of the effect of acute FFA elevation in 533	
trained and sedentary individuals.  Previous studies conducted in trained individuals using a saline 534	
infusion lacked such control (Matzinger et al., 2002; Schenk et al., 2009).     535	
 536	
In conclusion, this study has generated novel evidence that acute FFA elevation concurrent to a 537	
hyperinsulinaemic-euglycaemic clamp does not change PLIN protein content in skeletal muscle, but 538	
rather leads to a redistribution of PLIN2, PLIN3 and PLIN5 to an expanded LD pool in trained 539	
individuals only.  In contrast, no redistribution of PLIN proteins occurs in sedentary individuals.  This 540	
may be part of the mechanism by which trained individuals are able to channel fatty acids into IMTG. 541	
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Tables 767	
Table 1. Baseline characteristics of trained and sedentary participants 
 Trained (n=11) Sedentary (n=10) P value 
Sex (males/females) 6/5 4/6 0.98 
Age (y) 23 ± 1 21 ± 1 0.26 
BMI (kg.m-2) 22.2 ± 0.6 21.3 ± 0.6 0.31 
FFM (kg) 50.8 ± 3.7 40.9 ± 2.3 0.04 
Body fat (%) 19.9 ± 2.0 27.4 ± 3.5 0.07 
VO2max (ml.kg-1.min-1) 47.8 ± 2.0 38.0 ± 1.6 <0.01 
Baseline GIR (µmol glucose infused.kg FFM-
1.min-1) 66.1 ± 4.7 48.3 ± 5.7 0.03 
FFA at end of 6 hr lipid infusion (µmol.L-1) 600 ± 86 932 ± 105 0.03 
 768	
Values are means ± S.E.M.  BMI, body mass index; FFM, free fat mass; GIR, glucose infusion rate; 769	
FFA, free fatty acids. 770	
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Figure Legends 786	
 787	
Figure 1.  Representative immunofluorescence images co-stained for IMTG and PLIN5 that were used 788	
for colocalisation analysis from a trained participant.  Images for colocalisation analysis were obtained 789	
at 8x zoom from the central region of a cell (indicated by the white box; A).  IMTG were stained with 790	
BODIPY 493/503 (green; B), PLIN5 was stained red (C) and the subsequent merged images (D) were 791	
used to calculate colocalisation.  Image E shows the extracted overlying area and was used to calculate 792	
the relative association of PLIN5 with IMTG, and determine the number of PLIN5+ and PLIN5- LDs.  793	
Note that PLIN5 is associated with the majority, but not all, LDs.  Images were obtained at 8x zoom 794	
(white bar = 5 µm), except for A (2x zoom; white bar = 25 µm).  All images were obtained with the 795	
same resolution (1024 x 1024 pixels).  The same method was used for colocalisation analysis for PLIN2, 796	
PLIN3 and PLIN4. 797	
 798	
Figure 2.  A 6-h Intralipid infusion did not alter fibre-specific PLIN2 (A), PLIN3 (B), PLIN4 (C) and 799	
PLIN5 (D) protein expression in trained and sedentary individuals.  Fibre type-specific content of 800	
PLIN2, PLIN3 (E), PLIN4 (F) and PLIN5 was quantified from immunofluorescence images, where 801	
myosin heavy chain I (MHC I) (stained red) was combined with wheat germ agglutinin Alexa Fluor 802	
350 (WGA) to identify the cell border (stained blue) in skeletal muscle (G & H).  Positively stained 803	
fibres (red) are type I fibres, all other fibres are assumed to be type II fibres.  White bars represent 50 804	
µm.  *Significantly different compared to sedentary group (P<0.05).  †Significantly different than type 805	
I fibres (P<0.001).  There was a trend (P=0.06) for a difference in PLIN4 content between trained and 806	
sedentary participants in type I fibres only.  807	
 808	
Figure 3.  A 6-h Intralipid infusion alters fibre-specific IMTG content (A), LD density (B) and LD size 809	
(C).  Fibre type-specific content of IMTG was quantified from immunofluorescence images of muscle 810	
sections obtained at baseline (Bx1; D), and after 120 min (Bx2; E) and 360 min (Bx3; F) of lipid or 811	
glycerol infusion.  Panels G-I are corresponding images of myosin heavy chain I (MHC I) (stained red) 812	
in combination with wheat germ agglutinin Alexa Fluor 350 (WGA) to identify the cell border (stained 813	
blue) in skeletal muscle.  Positively stained fibres (red) are type I fibres, all other fibres are assumed to 814	
be type II fibres.  White bars represent 50 µm.  *Significantly different from Bx1 given fitness category 815	
and infusion status (P<0.05).  †Significantly different than type I fibres (P<0.001). 816	
 817	
Figure 4.  A 6-h lipid infusion alters the number of LDs with PLIN2 associated (PLIN2+ LDs) or not 818	
associated (PLIN2- LDs) differently between trained and sedentary individuals.  Analysis was 819	
performed in type I (A, B) and type II fibres (C, D).  *Significantly different from Bx1 given fitness 820	
category and infusion status (P<0.05).  †Significantly different between glycerol and lipid infusion 821	
within fitness category for equivalent biopsies. 822	
 823	
Figure 5.  A 6-h lipid infusion alters the number of LDs with PLIN3 associated (PLIN3+ LDs) or not 824	
associated (PLIN3- LDs) differently between trained and sedentary individuals.  Analysis was 825	
performed in type I (A, B) and type II fibres (C, D).  *Significantly different from Bx1 given fitness 826	
category and infusion status (P<0.05).  †Significantly different between glycerol and lipid infusion 827	
within fitness category for equivalent biopsies. 828	
 829	
Figure 6.  A 6-h lipid infusion does not alter the number of LDs with PLIN4 associated (PLIN3+ LDs) 830	
but does increase the number of LDs without PLIN4 associated (PLIN3- LDs) in trained and sedentary 831	
individuals.  Analysis was performed in type I (A, B) and type II fibres (C, D).  *Significantly different 832	
from Bx1 given fitness category and infusion status (P<0.05). 833	
 834	
Figure 7.  A 6-h lipid infusion alters the number of LDs with PLIN5 associated (PLIN5+ LDs) or not 835	
associated (PLIN5- LDs) differently between trained and sedentary individuals.  Analysis was 836	
performed in type I (A, B) and type II fibres (C, D).  *Significantly different from Bx1 given fitness 837	
category and infusion status (P<0.05).  †Significantly different between glycerol and lipid infusion 838	
within fitness category for equivalent biopsies. 839	
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